Inhibrx Biosciences Inc
INBX · US
Inhibrx Biosciences Inc is held by 2 of the 24 tracked investors in their latest 13F filings. The largest position is Viking Global Investors's at $106M, 0.30% of that portfolio. Versus the prior quarter, 0 added, 2 trimmed and 0 bought new. In the last 90 days insiders sold 0 times ($0) and bought 2 times on the open market.
Big investors holding this stock
Latest 13F of the 24 tracked investors. Common shares only.
| Investor | Value ($) | vs prior quarter |
|---|---|---|
| Viking Global Investors weight 0.30% · Q2 2026 |
106M | ▼ 22% |
| Norges Bank weight 0.00% · Q2 2026 |
8.6M | ▼ 32% |
Insider trades (90 days)
SEC Form 4| Insider | Trade | Amount ($) |
|---|---|---|
| Kayyem Jon Faiz Director · 9/23 |
Buy | 0.5M |
| Kayyem Jon Faiz Director · 9/16 |
Buy | 0.5M |
Questions
Which big investors own Inhibrx Biosciences Inc?
Viking Global Investors ($106M), Norges Bank ($8.6M), per their latest 13F filings.
Does Warren Buffett own Inhibrx Biosciences Inc?
Berkshire Hathaway did not report it in its latest 13F.
Does Korea's National Pension Service own Inhibrx Biosciences Inc?
Not in its latest 13F.
Have Inhibrx Biosciences Inc insiders been selling?
0 open-market sales ($0) and 2 purchases in the last 90 days; 0 of the sales were under pre-arranged 10b5-1 plans.
Restated and computed from SEC (13F, 13D/G, Form 4) and DART filings and NPS public data. Filings describe a past date and may differ from current holdings (13F: quarter end, up to 45 days later). Not investment advice.
Sources: SEC EDGAR, DART, data.go.kr (NPS), OpenFIGI. See Methodology for how figures are computed.